Details of the Drug Reposition

General Information of This Drug (ID: DMBH4FL)

Drug Name
BI 655066   DMBH4FL
Drug Type
Antibody

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Chronic plaque psoriasis DISBANIL EA90.0 Phase 3 [1]
------------------------------------------------------------------------------------
3 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Crohn disease DIS2C5Q8 DD70 Phase 2 [1]
Psoriatic arthritis DISLWTG2 FA21 Phase 2 [1]
Ankylosing spondylitis DISRC6IR FA92.0 Phase 2 [2]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 ClinicalTrials.gov (NCT02443298) Efficacy and Safety of BI 655066 in Patients With Severe Persistent Asthma.. U.S. National Institutes of Health.